Integration of Telemedicine Consultation Into a Tertiary Radiation Oncology Department: Predictors of Use, Treatment Yield, and Effects on Patient Population
Yasamin Sharifzadeh(Mayo Clinic in Arizona), Kimberly S. Corbin(University of Chicago), A. Amundson(Mayo Clinic in Arizona), Allison E. Garda(Mayo Clinic in Arizona), David M. Routman(Mayo Clinic in Arizona), William S. Harmsen(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Nadia N. Laack(Mayo Clinic), William G. Breen(Mayo Clinic in Arizona), Mark R. Waddle(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), Anantha Kollengode(Mayo Clinic in Arizona)
Cited by 1
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
|Neuro-Oncology|2013|942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827